Article Listing - FDA adds new AE data on label of Gilead's Truvada and Viread

BOOTS TO COPROMOTE W-L'S LOPID

10 February 1992

Boots Co has announced that its wholly-owned US subsidiary, Boots Pharmaceuticals Inc, has commenced the copromotion of Warner-Lambert subsidiary Parke-Davis'...

AEROBEC AUTOHALER EXTENSION

10 February 1992

3M Health Care's breath- actuated AeroBec Autohaler range in the UK, containing beclomethasone dipropionate, has now been extended to include...

NEW FORMULATION OF JANSSEN'S NIZORAL

10 February 1992

Janssen Pharmaceutical has launched a new unperfumed, less viscous formulation of its Nizoral (ketoconazole) shampoo in the UK. Nizoral, Janssen...

CELLTECH HALVES LOSSES IN FISCAL 1991

10 February 1992

The Celltech Group, which claims to be the largest independent biotechnology company in the UK, announced that it has halved...

SPAIN LOOKING TO GENERICS

10 February 1992

The full incorporation of Spain into the European Community, which takes effect on October 7, means that the country will...

US FDA TAKING LONGER TO APPROVE NEW DRUGS

10 February 1992

The US Food and Drug Administra-tion is taking longer to review new drugs, and in 1991 required an average of...

INDUSTRY RESPONSE TO JAPAN DRUG PRICE MOVES

10 February 1992

The Koseisho, Japan's Ministry of Health and Welfare, is in the process of clarifying how it intends to implement the...

STOCK MARKET COMMENTARY: TOKYO

10 February 1992

TOKYO: recovered to the 22,000 yen level for the first time since January 10, in continued low volume. But on...

STOCK MARKET COMMENTARY: EUROPE

10 February 1992

EUROPE: saw most stock markets down by the end of the reporting period, with FRANKFURT doing marg-inally better. Among the...

GOOD YEAR FOR SANOFI IN 1991

10 February 1992

In 1991 sales at the French health and beauty concern, Elf Sanofi, increased 5.8% to 19.6 billion French francs ($3.6...

Showing 94821-94830 of 95329 articles